Kondaveeti-Gordon U, Harrison R F, Barry-Kinsella C, Gordon A C, Drudy L, Cottell E
Human Assisted Reproduction, Ireland.
Fertil Steril. 1996 Oct;66(4):582-6. doi: 10.1016/s0015-0282(16)58571-9.
To determine the optimum menstrual cycle time to initiate a long-protocol gonadotropin-releasing hormone agonist (GnRH-a) down-regulation regimen before hMG stimulation before IVF.
Randomized, prospective, single, first cycle study.
University teaching hospital.
Eighty-six infertile couples undergoing IVF-ET attempt under rules for Ireland.
Gonadotropin-releasing hormone agonist administered intranasally from day 1 or 21 of menstrual cycle. Human menopausal gonadotropin commenced when pituitary down-regulation was confirmed.
Ovarian response, cancellation, fertilization, and pregnancy rates.
No significant differences found between day 1 and day 21 initiation. But starting on day 1 is more easily recognizable by patients and avoids the possibility of administering GnRH-a in the presence of an unsuspected pregnancy.
Both follicular and luteal phase initiation of GnRH-a long-protocol down-regulation are equally efficacious. In our clinical context, patients and management favor commencing on day 1.
确定在体外受精(IVF)前使用人绝经期促性腺激素(hMG)刺激前,启动长效促性腺激素释放激素激动剂(GnRH-a)降调节方案的最佳月经周期时间。
随机、前瞻性、单周期研究。
大学教学医院。
86对根据爱尔兰规定接受IVF-ET治疗的不育夫妇。
在月经周期的第1天或第21天经鼻给予促性腺激素释放激素激动剂。确认垂体降调节后开始使用人绝经期促性腺激素。
卵巢反应、取消治疗率、受精率和妊娠率。
第1天和第21天开始治疗之间未发现显著差异。但从第1天开始更易于患者识别,且避免了在意外妊娠情况下给予GnRH-a的可能性。
GnRH-a长效方案降调节在卵泡期和黄体期开始同样有效。在我们的临床环境中,患者和管理方倾向于在第1天开始治疗。